Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Mild Cognitive Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03461276
What this trial is testing

Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Araclon Biotech S.L. 134
Not applicableActive Not RecruitingNCT06755164
What this trial is testing

Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI

Who this might be right for
Mild Cognitive Impairment (MCI)AMCI - Amnestic Mild Cognitive ImpairmentNeurodegenerative Dementia+1 more
IRCCS San Raffaele 55
Not applicableWithdrawnNCT01819623
What this trial is testing

Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Large-scale testing (Phase 3)Study completedNCT01662882
What this trial is testing

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
Avid Radiopharmaceuticals 48
Post-approval studies (Phase 4)UnknownNCT05594355
What this trial is testing

Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI

Who this might be right for
Mild Cognitive Impairment (MCI)
Fundació ACE Institut Català de Neurociències Aplicades 100
Not applicableEnded earlyNCT01870518
What this trial is testing

Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI

Who this might be right for
Parkinson's DiseaseMild Cognitive ImpairmentDementia
St. Joseph's Hospital and Medical Center, Phoenix 13
Not applicableUnknownNCT05899777
What this trial is testing

Intervention Effect of Yizhi Baduanjin on Patients With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Shanghai University of Traditional Chinese Medicine 100
Testing effectiveness (Phase 2)Study completedNCT04032626
What this trial is testing

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Who this might be right for
Cognitive Impairment, MildCognitive DysfunctionAmyloid Plaque+2 more
St. Joseph's Hospital and Medical Center, Phoenix 15
Not applicableLooking for participantsNCT07672938
What this trial is testing

Effects of Hydroxytyrosol-Rich Olive Polyphenol Dietary Supplement Combined With Mediterranean Diet Adherence on the Cognitive Health of Patients With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment (MCI)
Panhellenic Federation of Alzheimer's Disease and Related Disorders 141
Not applicableStudy completedNCT06327633
What this trial is testing

Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive Impairment

Who this might be right for
Type 2 Diabetes MellitusMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Not applicableLooking for participantsNCT06598163
What this trial is testing

Five Lives MED to Improve Cognitive Function in Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
SharpTx 170
Not applicableUnknownNCT06380725
What this trial is testing

The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentDementia
Anhui Provincial Hospital 60
Not applicableWithdrawnNCT01782391
What this trial is testing

Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments

Who this might be right for
Mild Cognitive Impairment, So Stated
Charite University, Berlin, Germany
Not applicableStudy completedNCT04721093
What this trial is testing

Effects of Photobiomodulation on Changes in Cognitive Function and rCBF in MCI

Who this might be right for
Regional Cerebral Blood FlowMild Cognitive ImpairmentCognitive Function
Pusan National University Yangsan Hospital 14
Early research (Phase 1)Ended earlyNCT03819699
What this trial is testing

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 3
Testing effectiveness (Phase 2)Ended earlyNCT00582855
What this trial is testing

Effect of AQW051 in Patients With Memory Impairment

Who this might be right for
Mild Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Novartis Pharmaceuticals 54
Post-approval studies (Phase 4)Study completedNCT05531591
What this trial is testing

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

Who this might be right for
DepressionDementiaMild Cognitive Impairment+5 more
Centre for Addiction and Mental Health 87
Not applicableStudy completedNCT02110043
What this trial is testing

Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS

Who this might be right for
Mild Cognitive Impairment (MCI)
Charite University, Berlin, Germany 21
Testing effectiveness (Phase 2)Study completedNCT01429623
What this trial is testing

A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentDementia
Avraham Pharmaceuticals Ltd 210
Early research (Phase 1)Study completedNCT04711486
What this trial is testing

Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Charite University, Berlin, Germany 19
Next Page